Blockchain Registration Transaction Record

NanoViricides, Inc. Updates Antiviral Pipeline with Potential Breakthrough Treatment for Measles and MPox

NanoViricides, Inc. provides a strategic update on its antiviral pipeline with NV-387 as a potential breakthrough treatment for Measles and MPox. The company aims to fill critical gaps in global antiviral preparedness by developing treatments for these diseases amid rising case counts and vaccine failures.

NanoViricides, Inc. Updates Antiviral Pipeline with Potential Breakthrough Treatment for Measles and MPox

This news matters as NanoViricides aims to address critical gaps in global antiviral preparedness by developing NV-387 as a treatment for Measles and MPox. With rising global case counts and vaccine failures, the company's strategic update provides hope for effective antiviral solutions in the fight against these diseases.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x3f12ebb507666c8d3d4dab7ebab326a5c77820dd99d8b3ccbf0697f8061c12ff
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintharpSSa7-66426313bfe5d310a6fa79c359071760